This support enables the promotion of leading edge research into the causes and potential cures of many types of adult and pediatric arthritis such as rheumatoid arthritis, systemic lupus and osteoarthritis, among others.

It also encourages and sustains the training of young physicians and scientists to become the next generation of leaders in the field of rheumatic diseases.

The Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center was created by the U.S. Congress in 1979 to posthumously honor the stage and screen actress who focused national attention on the need for greater resources for scientific studies of this disease and better information for the public. A single Congressional contribution of $800,000 was given to UCSF for this purpose, and Dr. Ephraim Engleman, then serving as the Chief of Rheumatology at UCSF, became founding Director.